The global surrogacy market is anticipated to grow at a CAGR of around 6.8% during the forecast period 2021 to 2028 and to reach around US$ 9.9 Bn by 2028.
Market Dynamics
Changing lifestyle pattern is affecting the consumer’s health sometime resulting in infertility, major players are focused on developing advanced solutions, along with rising awareness among consumers is resulting in demand for surrogacy these are major factors expected to drive the growth of global market. According to Centers for Disease Control and Prevention every year, millions of American families struggle with infertility for every 100 couples, 12 to 13 report they’ve experienced trouble getting pregnant. About 7.3 million women of childbearing age in the U.S. have used fertility treatments to get pregnant. In addition, infertility impacts approximately in 1 in 7 Americans and in 2018, average fertility patient paid over US$ 22,000 per “cycle,” with over 10,000 IVF patients reporting.
Business development activities by major player with the focus to increase the customer base and enhance the profit ration is another factor expected to augment the growth of target market.
In 2016, Cooper Surgical Inc. a global healthcare company that deals with health care medical instruments, devices and disposables acquired Wallace Pharmaceuticals located in India. This acquisition is expected to help the company to enhance the product portfolio of IVF.
In 2015, Irvine Scientific a global leader in design, manufacture, and distribution of products to the industrial cell culture entered in strategic partnership with Biotech Inc. This partnership is expected to help the company to strengthen its position in US market.
In 2020, IVF Spring Fertility Clinic located in India focused on digital marketing campaign in order to create awareness among consumers related to infertility and availability of treatment options. This is expected to create new business opportunities for them and enhance the customer base.
In 2017, Genea a leading players in fertility that offers treatments, such as IVF in collaboration with Merck opened Fertility Centre of Excellence in Bangkok. This is expected to help the company to enhance the business presence.
High government spending on development of present healthcare infrastructure for R&D activities along with deployment of advanced equipments in hospitals in order to facilitate the treatment are factors expected to support the growth of target market.
However, factors such as high cost of the procedure and stringent government regulation related to commercial surrogacy are expected to hamper the growth of global surrogacy market. In addition, low success rate of IVF treatment is another factor expected to challenge the growth of target market.
Increasing R&D activities by major players advancements in IVF treatment, along with focus on introduction of cost-effective treatment are factors responsible to create new opportunities for players operating in the target market over the forecast market. In addition, increasing partnership between regional and international players is expected to support the revenue traction of target market.
Segment Analysis by Region
The market in North America is expected to account for significant revenue share owing to large number of patients suffering from infertility issues. In addition, presence of large number of players operating in the country, availability of advanced infrastructure for R&D activities, along with focus on introduction of innovative solutions are factors expected to support the growth of target market.
Increasing merger and acquisition activities for enhancing the customer base and increase the revenue share are factors expected to support the growth of regional market.
Competitive Landscape
The global market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Report coverage
|
Market
|
Global Surrogacy Market
|
|
Analysis Period
|
2017 - 2028
|
|
Base Year
|
2020
|
|
Forecast Data
|
2021 - 2028
|
|
Market Stratification
|
Type, Technology, Age Group, End Use and Geography
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
|
Surrogacy Market Segment Analysis, 2020
The global market is segmented into type, technology, age group, and end use. The technology segment is bifurcated into intrauterine insemination (IUI), in-vitro fertilization (IVF), and others. Among technology the in-vitro fertilization (IVF) segment is expected to account for major revenue share in the global market due to rapid technological advancements by major players.
The end use segment is further divided into hospitals, fertility clinics, and others. The hospital segment is expected to account for significant revenue share in the target segment due to high government spending on development of infrastructure along with availability of reimbursement policies.
The players profiled in the report are Scanfert AVA Clinic, Bourn Hall Fertility Clinic, Nova IVI Fertility, Ovation Fertility, Bangkok IVF Center, Extraordinary Conceptions, Cardone & Associates Reproductive Medicine & Infertility, LLC, New Hope Fertility Center, IVI-RMA Global, Max Healthcare, and Growing Generations, LLC.
Market Segmentation
Market By Mode of Type
Gestational surrogacy
Traditional surrogacy
Market By Technology
Intrauterine insemination (IUI)
In-vitro fertilization (IVF)
- Classical/standard IVF
- Intracytoplasmic sperm injection (ICSI)
Others
Market By Age Group
Below 35 years
35-37 years
38 - 39 years
40-42 years
43-44 years
Over 44 years
Market By End User
Hospitals
Fertility clinics
Others
Market By Region
North America
• U.S.
• Canada
Europe
• U.K.
• Germany
• France
• Spain
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
CHAPTER 1.Industry Overview of Surrogacy
1.1.Definition and Scope
1.1.1.Definition of Surrogacy
1.1.2.Market Segmentation
1.1.3.Years Considered for the Study
1.1.4.Assumptions and Acronyms Used
1.1.4.1.Market Assumptions and Market Forecast
1.1.4.2.Acronyms Used in Global Surrogacy Market
1.2.Summary
1.2.1.Executive Summary
1.2.2.Surrogacy Market By Mode of Type
1.2.3.Surrogacy Market By Technology
1.2.4.Surrogacy Market By Age Group
1.2.5.Surrogacy Market By End-User
1.2.6.Surrogacy Market by Regions
CHAPTER 2.Research Approach
2.1.Methodology
2.1.1.Research Programs
2.1.2.Market Size Estimation
2.1.3.Market Breakdown and Data Triangulation
2.2.Data Source
2.2.1.Secondary Sources
2.2.2.Primary Sources
CHAPTER 3.Market Dynamics And Competition Analysis
3.1.Market Drivers
3.1.1.Driver 1
3.1.2.Driver 2
3.2.Restraints and Challenges
3.2.1.Restrain 1
3.2.2.Restrain 2
3.3.Growth Opportunities
3.3.1.Opportunity 1
3.3.2.Opportunity 2
3.4.Porter’s Five Forces Analysis
3.4.1.Bargaining Power of Suppliers
3.4.2.Bargaining Power of Buyers
3.4.3.Threat of Substitute
3.4.4.Threat of New Entrants
3.4.5.Degree of Competition
3.5.Regulatory Compliance
3.6.Competitive Landscape, 2020
3.6.1.Player Positioning Analysis
3.6.2.Key Strategies Adopted By Leading Players
CHAPTER 4.Surrogacy Market By Mode of Type
4.1.Introduction
4.2.Surrogacy Revenue By Mode of Type
4.2.1.Surrogacy Revenue (US$ Mn) and Forecast, By Mode of Type, 2017 - 2028
4.2.2.Gestational surrogacy
4.2.2.1.Gestational surrogacy Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
4.2.3.Traditional surrogacy
4.2.3.1.Traditional surrogacy Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
CHAPTER 5.Surrogacy Market Revenue By Technology
5.1.Introduction
5.2.Surrogacy Revenue (US$ Mn) By Technology
5.2.1.Surrogacy Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
5.2.2.Intrauterine insemination (IUI)
5.2.2.1.Intrauterine insemination (IUI) Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
5.2.3.In-vitro fertilization (IVF)
5.2.3.1.In-vitro fertilization (IVF) Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
5.2.3.2.Classical/standard IVF
5.2.3.2.1.Classical/standard IVF Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
5.2.3.3.Intracytoplasmic sperm injection (ICSI)
5.2.3.3.1.Intracytoplasmic sperm injection (ICSI) Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
5.2.4.Others
5.2.4.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
CHAPTER 6.Surrogacy Market By Age Group
6.1.Introduction
6.2.Surrogacy Revenue (US$) By Age Group
6.2.1.Surrogacy Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
6.3.Below 35 years
6.3.1.Below 35 years Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
6.4.35-37 years
6.4.1.35-37 years Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
6.5.38 - 39 years
6.5.1.38 - 39 years Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
6.6.40-42 years
6.6.1.40-42 years Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
6.7.43-44 years
6.7.1.43-44 years Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
6.8.Over 44 years
6.8.1.Over 44 years Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
CHAPTER 7.Surrogacy Market By End-User
7.1.Introduction
7.2.Surrogacy Revenue (US$) By End-User
7.2.1.Surrogacy Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
7.3.Hospitals
7.3.1.Hospitals Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
7.4.Fertility clinics
7.4.1.Fertility clinics Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
7.5.Others
7.5.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
CHAPTER 8.North America Surrogacy Market By Country
8.1.North America Surrogacy Overview
8.2.U.S.
8.2.1.U.S. Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
8.2.2.U.S. Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
8.2.3.U.S. Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
8.2.4.U.S. Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
8.3.Canada
8.3.1.Canada Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
8.3.2.Canada Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
8.3.3.Canada Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
8.3.4.Canada Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
8.4.North America PEST Analysis
CHAPTER 9.Europe Surrogacy Market By Country
9.1.Europe Surrogacy Market Overview
9.2.U.K.
9.2.1.U.K. Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
9.2.2.U.K. Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
9.2.3.U.K. Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
9.2.4.U.K. Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
9.3.Germany
9.3.1.Germany Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
9.3.2.Germany Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
9.3.3.Germany Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
9.3.4.Germany Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
9.4.France
9.4.1.France Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
9.4.2.France Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
9.4.3.France Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
9.4.4.France Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
9.5.Spain
9.5.1.Spain Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
9.5.2.Spain Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
9.5.3.Spain Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
9.5.4.Spain Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
9.6.Rest of Europe
9.6.1.Rest of Europe Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
9.6.2.Rest of Europe Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
9.6.3.Rest of Europe Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
9.6.4.Rest of Europe Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
9.7.Europe PEST Analysis
CHAPTER 10.Asia Pacific Surrogacy Market By Country
10.1.Asia Pacific Surrogacy Market Overview
10.2.China
10.2.1.China Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
10.2.2.China Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
10.2.3.China Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
10.2.4.China Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
10.3.Japan
10.3.1.Japan Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
10.3.2.Japan Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
10.3.3.Japan Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
10.3.4.Japan Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
10.4.India
10.4.1.India Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
10.4.2.India Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
10.4.3.India Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
10.4.4.India Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
10.5.Australia
10.5.1.Australia Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
10.5.2.Australia Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
10.5.3.Australia Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
10.5.4.Australia Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
10.6.South Korea
10.6.1.South Korea Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
10.6.2.South Korea Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
10.6.3.South Korea Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
10.6.4.South Korea Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
10.7.Rest of Asia-Pacific
10.7.1.Rest of Asia-Pacific Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
10.7.2.Rest of Asia-Pacific Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
10.7.3.Rest of Asia-Pacific Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
10.7.4.Rest of Asia-Pacific Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
10.8.Asia Pacific PEST Analysis
CHAPTER 11.Latin America Surrogacy Market By Country
11.1.Latin America Surrogacy Market Overview
11.2.Brazil
11.2.1.Brazil Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
11.2.2.Brazil Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
11.2.3.Brazil Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
11.2.4.Brazil Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
11.3.Mexico
11.3.1.Mexico Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
11.3.2.Mexico Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
11.3.3.Mexico Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
11.3.4.Mexico Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
11.4.Rest of Latin America
11.4.1.Rest of Latin America Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
11.4.2.Rest of Latin America Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
11.4.3.Rest of Latin America Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
11.4.4.Rest of Latin America Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
CHAPTER 12.Middle East & Africa Surrogacy Market By Country
12.1.Middle East & Africa Surrogacy Market Overview
12.2.Saudi Arabia
12.2.1.Saudi Arabia Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
12.2.2.Saudi Arabia Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
12.2.3.Saudi Arabia Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
12.2.4.Saudi Arabia Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
12.3.UAE
12.3.1.UAE Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
12.3.2.UAE Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
12.3.3.UAE Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
12.3.4.UAE Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
12.4.Rest of Middle East & Africa
12.4.1.Rest of Middle East & Africa Surrogacy Market Revenue (US$ Mn) and Forecast By Mode of Type, 2017 - 2028
12.4.2.Rest of Middle East & Africa Surrogacy Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
12.4.3.Rest of Middle East & Africa Surrogacy Market Revenue (US$ Mn) and Forecast By Age Group, 2017 - 2028
12.4.4.Rest of Middle East & Africa Surrogacy Market Revenue (US$ Mn) and Forecast By End-User, 2017 - 2028
CHAPTER 13.Player Analysis Of Surrogacy
13.1.Surrogacy Market Company Share Analysis
13.2.Competition Matrix
13.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2.New Product Launches and Product Enhancements
13.2.3.Mergers And Acquisition In Global Surrogacy Market
13.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14.Company Profile
14.1.Scanfert AVA Clinic
14.1.1.Company Snapshot
14.1.2.Business Overview
14.1.3.Financial Overview
14.1.3.1.Revenue (US$ Mn), 2020
14.1.3.2.Scanfert AVA Clinic 2020 Surrogacy Business Regional Distribution
14.1.4.Product/ Service and Specification
14.1.5.Recent Developments & Business Strategy
14.1.6.Manufacturing Plant Footprint Analysis
14.2.Bourn Hall Fertility Clinic
14.3.Nova IVI Fertility
14.4.Ovation Fertility
14.5.Bangkok IVF Center
14.6.Extraordinary Conceptions
14.7.Cardone & Associates Reproductive Medicine & Infertility, LLC New Hope Fertility Center
14.8.IVI-RMA Global
14.9.Max Healthcare
14.10.Growing Generations, LLC.
14.11.Others
![Surrogacy Market (By Mode of Type: Gestational surrogacy, Traditional surrogacy; By Technology: Intrauterine insemination (IUI), In-vitro fertilization (IVF) [Classical/standard IVF, Intracytoplasmic sperm injection (ICSI)], Others; By Age Group: Below 35 years, 35-37 years, 38 - 39 years, 40-42 years, 43-44 years, Over 44 years; By End User: Hospitals, Fertility clinics, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2021 - 2028](assets/images/format-png.png "Surrogacy Market (By Mode of Type: Gestational surrogacy, Traditional surrogacy; By Technology: Intrauterine insemination (IUI), In-vitro fertilization (IVF) [Classical/standard IVF, Intracytoplasmic sperm injection (ICSI)], Others; By Age Group: Below 35 years, 35-37 years, 38 - 39 years, 40-42 years, 43-44 years, Over 44 years; By End User: Hospitals, Fertility clinics, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2021 - 2028")
